This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/chebi/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/bindingdb/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/pubchem-compound/
n5http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01864/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB01864
rdf:type
n3:Drug
n3:description
Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes. [PubChem]
n3:group
experimental
owl:sameAs
n5:DB01864 n13:DB01864
dcterms:title
5'-Guanosine-Diphosphate-Monothiophosphate
adms:identifier
n8:43000 n9:DB01864 n11:35866 n12:46507592 n14:GSP n15:6324623
n3:IUPAC-Name
n6:271B4E34-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B4E3A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B4E39-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B4E36-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B4E37-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B4E38-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B4E32-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B4E33-363D-11E5-9242-09173F13E4C5 n6:271B4E30-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B4E31-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n6:271B4E40-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B4E41-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B4E3B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B4E3C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B4E3E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B4E3D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B4E3F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B4E46-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B4E48-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B4E49-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B4E45-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B4E44-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B4E47-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B4E35-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B4E42-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B4E43-363D-11E5-9242-09173F13E4C5